Subscribe

Breaking News

Adverse Effects Identified Following Faricimab Treatment for Eye Conditions
Adverse Effects Identified Following Faricimab Treatment for Eye Conditions Oct 15, 2024 Researchers from the University Hospital Zurich have reported cases of sterile intraocular inflammation, including severe retinal vasculitis, associated with faricimab injections.
Eye Drop Company Faces FDA Scrutiny Again Over Unapproved Products
Eye Drop Company Faces FDA Scrutiny Again Over Unapproved Products Sep 19, 2024 The FDA has issued a warning letter to the Regenerative Processing Plant, manufacturer of Regener-Eyes Pro and Lite eye drops, for marketing unapproved products claiming to treat dry eyes.
Maestro®: The Sinusoidal IOL
Maestro®: The Sinusoidal IOL Sep 18, 2024 VSY Biotechnology introduced the Maestro® Sinusoidal IOL at ESCRS 2024, featuring SVT. This innovative trifocal lens enhances visual acuity, contrast sensitivity, and light transmission, offering a cutting-edge solution for presbyopia management.

 

a banner for OBN's Spotlight TV series. Showing 5 people in ophthalmic sector

Industry News

Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu as Chief Medical Officer
Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu as Chief Medical Officer Nov 06, 2024 Tarsus Pharmaceuticals has announced the appointment of Elizabeth Yeu, MD, as Chief Medical Officer, effective November 4, 2024
FDA Clears IND Application for HG202 Gene Therapy in Wet AMD
FDA Clears IND Application for HG202 Gene Therapy in Wet AMD Nov 06, 2024 The U.S. FDA has granted investigational drug clearance for HG202, a pioneering CRISPR/Cas13Y RNA-editing therapy developed by HuidaGene to treat neovascular (wet) age-related macular degeneration (AMD).
FDA Grants Fast Track Designation to Oral Molecule FLQ-101 for Retinopathy of Prematurity
FDA Grants Fast Track Designation to Oral Molecule FLQ-101 for Retinopathy of Prematurity Nov 06, 2024 The U.S. FDA has granted fast track designation to FLQ-101, FELIQS’ oral and intravenous solution targeting retinopathy of prematurity (ROP).

Ophthalmic Research News

Color Vision Deficiency May Affect Diagnosis of Choroidal Conditions
Color Vision Deficiency May Affect Diagnosis of Choroidal Conditions Sep 24, 2924 Color vision deficiency (CVD) can affect an ophthalmologist’s ability to differentiate between choroidal melanoma and choroidal nevus, potentially leading to misdiagnoses.
The Relationship Between Blood Pressure and Intraocular Pressure in Glaucoma Risk
The Relationship Between Blood Pressure and Intraocular Pressure in Glaucoma Risk Oct 01, 2024 Evidence suggests that ocular perfusion pressure is a strong risk factor for glaucoma. Ocular perfusion pressure is the relationship between the eye pressure and the blood pressure.
Nicotine's Potential in Myopia Control: Animal Research Findings
Nicotine's Potential in Myopia Control: Animal Research Findings Sep 27, 2024 Researchers led by Dr. Kate Thomson from the University of Canberra have found that nicotine, when administered either as an intravitreal injection or topical eye drop, significantly inhibited the development of FDM and LIM in chicks.

Ophthalmic Blog

Global Myopia Rates in Children and Teens Expected to Surpass 740 Million by 2050
Global Myopia Rates in Children and Teens Expected to Surpass 740 Million by 2050 Oct 01, 2024 A new analysis published in the British Journal of Ophthalmology reveals that nearly one in three children and teens worldwide is expected to be affected by myopia by 2050, translating to over 740 million cases.
Lamprey's Eye Disease: Separating Fact from Fiction
Lamprey's Eye Disease: Separating Fact from Fiction Sep 30, 2024 Lamprey Eye Disease, also known as "Lamprey Disease," is a hoax that has been circulating on the internet for several years. The hoax claims that a parasitic fish known as the lamprey is responsible for a disease that can cause blindness in humans.
ChatGPT-4.0 Demonstrates Promise in Addressing Retinal Disease Queries
ChatGPT-4.0 Demonstrates Promise in Addressing Retinal Disease Queries Aug 27, 2024 A recent study highlights the potential of ChatGPT-4.0 in accurately answering questions related to retinal diseases, covering diagnostic criteria, treatment guidelines, and management strategies.
Ophthalmology Breaking News Subscribe